30-Oct-2026 14:08:19

ONESOURCE : RECEIVES USFDA EIR WITH VAI CLASSIFICATION FOR BENGALURU SPD FACILITY

• USFDA issued Establishment Inspection Report for the Sterile Product Division facility in Bengaluru with Voluntary Action Indicated (VAI) classification • Report follows inspection of the facility conducted from June 22 to June 30, 2026 • SPD facility is integral to sterile manufacturing capabilities supporting global partners • Adds to regulatory track record of the pure-play specialty pharma CDMO platform • Platform spans four modalities: drug-device combination, biologics, sterile injectables and soft gelatin capsules

Onesource Specialty Pharma Ltd

← Back to feed